To evaluate the feasibility, reproducibility, and technical quality of a dynamic contrast material-enhanced isotropic three-dimensional (3D) volumetric interpolated breath-hold hepatic magnetic resonance (MR) imaging examination.
thicknesses and gaps between two-dimensional (2D) imaging sections, which contribute to partial volume artifacts.
Third, accurate three-dimensional (3D) rendering of segmental and vascular anatomy by means of contrast-enhanced studies can be helpful for surgical planning, including assessment of the feasibility of hepatic resection (10) and hepatic transplantation (11, 12) . Although these features would be achieved best with isotropic 3D imaging, until recently, dynamic T1-weighted magnetic resonance (MR) imaging of the liver has been limited predominantly to 2D imaging.
In an earlier work (13), we described an MR approach that incorporates interpolation schemes and intermittent fat-saturation pulses to achieve fat-saturated 3D images of the entire liver with nearly isotropic pixel size (approximately 2 mm in all three dimensions) in less than 25 seconds. We refer to this approach as the volumetric interpolated breath-hold examination. On the basis of qualitative and quantitative measures, image quality for this 3D method was shown to be comparable to or improved over conventional 2D gradient-echo imaging when used for nonenhanced or delayed contrast-enhanced imaging of the abdomen. As a breath-hold technique, volumetric interpolated breath-hold examinations can be performed repeatedly following injection of 0.1 mmol of gadopentetate dimeglumine per kilogram of body weight to obtain dynamic 3D images of the liver. We hypothesize that the nearly isotropic resolution can facilitate reconstruction methods such as multiplanar reconstruction and angiographic postprocessing for definition of vascular and segmental anatomy.
The purpose of this study was to evaluate the feasibility and technical quality of an isotropic volumetric interpolated breath-hold examination as a dynamic 3D imaging method in 50 consecutive patients referred for MR examination of the liver, including patients with cirrhosis. To ensure accurate timing of the arterial phase acquisition, a timing examination was implemented by using a test dose of contrast material. To assess reproducibility of the imaging method, we compared baseline results with results from repeat studies performed within 6 months.
MATERIALS AND METHODS
Fifty-five patients were referred for clinical reasons for contrast-enhanced MR imaging of the liver during the study period. Of these, five (9%) were excluded from study-four because of an inability to suspend respiration for 15 seconds or more and one because obesity precluded use of the torso phased-array coil. The 50 patients who formed the study cohort had a mean age of 57 years (age range, 34-87 years; 24 women, 26 men). Written informed consent for administration of contrast material was obtained from all patients. Referring diagnoses included evaluation for the following: metastatic disease (n ϭ 11), indeterminate hepatic lesion (n ϭ 10), hepatoma (n ϭ 8), cirrhosis (n ϭ 5), hepatitis or abnormal hepatic function test results (n ϭ 7), and hemochromatosis (n ϭ 2).
Within 6 months of the initial study, 10 patients (20%) were referred for repeat MR examination. These patients underwent imaging with the same imaging protocol, and reproducibility was evaluated.
MR Imaging Protocol
All patients underwent imaging with use of a 1.5-T MR system (Vision; Siemens, Erlangen, Germany) with highperformance gradients (25 mT/m maximum gradient strength and 600-µsec rise time) and a torso phased-array coil. Before the study, a 22-gauge intravenous catheter was placed in an arm vein and attached to an MR-compatible power injector (Spectris; Medrad, Pittsburgh, Pa). Before volumetric interpolated breathhold examination, all patients underwent imaging with use of fast, short inversion time inversion-recovery and T1-weighted in-phase and out-of-phase gradient-echo sequences according to our routine protocol.
The volumetric interpolated breathhold examination is a 3D spoiled gradientecho acquisition with 4.2/1.8 (repetition time msec/echo time msec), a flip angle of 12°, and a bandwidth of 488 Hz/pixel. Sequence details have been reported previously (13) and are summarized briefly as follows: symmetric echo (160 points) in the read direction (k x , left-to-right) and 80% partial Fourier sampling (128 of 160 points) in the phase-encoding direction (k y , anterior-to-posterior), whereby each 160 ϫ 160 partition is interpolated to a 256 ϫ 256 matrix.
By using a field of view of 300-400 mm, in-plane spatial resolution of 2.5 mm or less is attained for the initial matrix of 160 ϫ 160, whereas the imaging matrix of 256 ϫ 256 yields a pixel size of 1.6 mm or less. In the section-select, or partition, direction (k z , superior-to-inferior), asymmetric echo sampling is performed to obtain 40-56 data points that are then interpolated by using zero filling (sinc interpolation) to produce 80-112 partitions. The 3D sequence incorporates a frequency-selected fat-saturation pulse prior to each partition (section) loop. Each partition loop is centric reordered to maximize fat saturation.
Section thicknesses ranged from 160 to 200 mm to ensure full coverage of the liver and yielded a partition thickness of 2.0-2.5 mm. For all studies, anatomic coverage was defined to include the entire liver. The mean acquisition time for volumetric interpolated breath-hold examination was 22.7 seconds (range, 18-28 seconds).
For all patients, a nonenhanced volumetric interpolated breath-hold examination was performed first and was followed by a timing examination and three dynamically acquired contrast-enhanced volumetric interpolated breath-hold acquisitions. The timing examination was performed according to the method described by Earls et al (14) by using a 1-mL test dose of gadopentetate dimeglumine (Magnevist; Berlex, Wayne, NJ). For contrast-enhanced studies, all patients received 19 mL of contrast material for a mean dose of 0.14 mmol/kg (range, 0.08-0.19 mmol/kg). The volumetric interpolated breath-hold acquisition was then repeated twice at 45-second intervals for portal vein and equilibrium phase acquisitions. All volumetric interpolated breath-hold studies were performed during breath holding at the end of expiration. The total table time for the dynamic volumetric interpolated breath-hold portion of the examination, including the timing examination, averaged 9 minutes Ϯ 3 (SD).
Image Analysis
Qualitative assessment.-Overall image quality was evaluated subjectively by two investigators (M.T.L., V.S.L.) by means of consensus. Adequacy of spatial coverage to include the entire liver was assessed. The conspicuity of hepatic arteries for each contrast-enhanced data set was evaluated on a scale of 0-2: 0, no arteries identified; 1, arteries seen but demonstrating mild enhancement; 2, conspicuous arterial enhancement. The conspicuity of the portal vein and segmental branches was evaluated similarly for portal venous phase volumetric interpolated breathhold acquisitions.
Region-of-interest analysis.-By using the commercial software of our system, re-gion-of-interest analysis was performed by one investigator (M.T.L.). Signal intensity (SI) measurements of the hepatic artery, portal vein, hepatic vein, inferior vena cava, and aorta were recorded for each of the three volumetric interpolated breath-hold acquisitions for all patients. Vessels were identified on the enhanced images, and regions of interest were copied to identical sections on the nonenhanced studies. In addition, SI was measured in retroperitoneal fat, air, and liver, with care taken to exclude vessels from the regions of interest.
Several parameters were calculated from the measured SI. For all tissues and vessels, contrast-to-noise ratio (CNR) was calculated by using retroperitoneal fat as the reference and was defined as (SI T Ϫ SI fat )/noise, where SI T is the SI of tissues and vessels and SI fat is the SI of fat. Noise was defined as the SD of SI measured in air outside the body; midline areas that could be affected by ghosting from vessels and respiratory artifact were avoided.
Relative enhancement was defined as (SI post Ϫ SI pre )/SI pre , where SI post is the SI after the administration of contrast material and SI pre is the SI before the administration of contrast material, and was measured for the liver and all vessels. The venous-to-arterial enhancement ratio for a given enhanced study was defined as (SI postV Ϫ SI preV )/(SI postA Ϫ SI preA ), where V is vein, A is artery, and a ratio of 0 represents the ideal arterial phase image free of venous enhancement. This ratio was used as a measure of portal venous and hepatic venous enhancement relative to hepatic arterial enhancement during arterial phase volumetric interpolated breathhold examination.
We also calculated the percentage of total hepatic parenchymal enhancement seen during arterial phase imaging as (SI apL Ϫ SI preL )/(SI pvpL Ϫ SI preL ), where SI ap is the SI during the arterial phase, SI pvp is the SI during the portal venous phase, and L is liver.
Hepatic anatomic assessment.-Patterns of hepatic vascular (arterial, portal venous, and hepatic venous) anatomy were assessed retrospectively by two investigators (V.S.L, M.T.L.) by means of consensus by using commercially available software (NUMARIS and VIRTUOSO; Siemens) to obtain multiplanar reconstruction images of the source data. Hepatic arterial anatomy was classified according to the Michels classification (15) , and additional variants were specified. Briefly, the Michels classification is summarized as follows: I, proper hepatic artery divides into right and left hepatic arteries (''normal anatomy''); II, left hepatic artery replaced to left gastric artery; III, right hepatic artery replaced to superior mesenteric artery; IV, both right and left hepatic arteries replaced; V, accessory left hepatic artery replaced to left gastric artery; VI, accessory right hepatic artery replaced to superior mesenteric artery; VII, accessory right and left hepatic arteries; VIII, replaced right hepatic artery and accessory left hepatic artery or, conversely, replaced left hepatic artery with accessory right hepatic artery; IX, proper hepatic artery arising from the superior mesenteric artery; and X, proper hepatic artery arising from the left gastric artery.
Patterns of hepatic venous and portal venous anatomy were also classified by using source images (16) (17) (18) . Variations in the confluence of the main hepatic veins were noted. The presence of any inferior hepatic veins was recorded, as was depiction of separate hepatic veins directly draining the caudate lobe. The pattern of intrahepatic portal venous branching was characterized, and the number of segmental portal branches seen was recorded. The presence of portal venous thrombosis and cavernous transformation was also assessed.
Statistical Analysis
The two-tailed Student t test was used to compare quantitative image parameters measured for all volumetric interpolated breath-hold acquisitions. Patient circulation time and image quality parameters were also compared by using the Student t test for patients with (n ϭ 17) and those without (n ϭ 34) cirrhosis of the liver as determined by means of MR imaging features (19) . For studies of reproducibility, image quality parameters for baseline and repeat examinations were compared by using paired t test analysis.
RESULTS
Volumetric interpolated breath-hold studies, including timing examinations, were successfully completed in all 50 patients (Fig 1) . In one patient, power injector malfunction resulted in injection of less than the typical 19 mL of gadolinium chelate, although the relative enhancement values of the hepatic arteries and liver were similar to the mean values.
Seventeen patients (34%) had MR findings of cirrhosis at baseline examination. Their mean age (57.3 years Ϯ 9.3) was not significantly different from that of patients without cirrhosis (55.2 years Ϯ 16.8; P ϭ .6). There was also no statistically significant difference in circulation time between patients with and those without MR findings of cirrhosis (P ϭ .7).
Image Quality
In two studies (4%), a small portion of the dome of the liver was excluded from the dynamic volumetric interpolated breath-hold study, presumably because of variations in patient breath-holding technique. Overall, conspicuity of the hepatic arteries on arterial phase volumetric interpolated breath-hold studies was high (score ϭ 2) for all but one patient (98%); in the one patient with low arterial conspicuity (score ϭ 0), arterial anatomy was defined by using portal venous phase images. Portal venous enhancement was graded as highly conspicuous on all but one study (98%).
CNRs for liver and vascular structures relative to retroperitoneal fat for nonenhanced, arterial, portal venous, and equilibrium phase studies are shown in Table 1 .
The relative enhancement ratio of hepatic parenchyma during arterial phase volumetric interpolated breath-hold examination averaged 2.2 Ϯ 1.5, whereas values during portal venous and equilibrium enhancement phases were significantly higher at 3.9 Ϯ 2.1 and 3.8 Ϯ 2.3, respectively (P Ͻ .001). Hepatic enhancement decreased minimally between portal venous phase and equilib- Figure 2 . Graph shows mean SI measurements (n ϭ 50) for nonenhanced and dynamic contrast-enhanced volumetric interpolated breath-hold (VIBE) studies; error bars indicate 1 SD. The significantly higher SI of the aorta and hepatic artery (the latter is not shown) compared with hepatic parenchymal and venous enhancement during the first contrast-enhanced acquisition (Arterial Phase) illustrates the preferential arterial enhancement attained when volumetric interpolated breath-hold acquisition is timed by using a test bolus of contrast material. ᭜ ϭ aorta, ϭ liver, ᭹ ϭ portal vein, ᭡ ϭ hepatic vein. rium phase acquisitions (P ϭ .8). During arterial phase, the liver enhanced a mean of 29% Ϯ 30 of maximal enhancement.
Mean SI values of liver and major vessels for each of the volumetric interpolated breath-hold acquisitions are plotted in Figure 2 . During arterial phase, aortic SI demonstrated an increase greater than 600% over nonenhanced images and was significantly greater during arterial phase than during portal venous or equilibrium phases (P Ͻ .05). Hepatic venous and inferior vena caval enhancement were not significantly different between portal venous and equilibrium phases (P Ͼ .4), whereas hepatic arterial enhancement decreased slightly but not significantly on portal venous phase studies (P Ͼ .2).
We also calculated venous-to-arterial enhancement ratios, for which an ideal arterial phase study free of venous enhancement would have a ratio of 0. During the arterial phase acquisition, the portal vein demonstrated 39% as much enhancement as the hepatic artery did (venous-to-arterial ratio, 0.39 Ϯ 0.38). The hepatic vein demonstrated a mean of 15% as much enhancement as the hepatic artery did (venous-to-arterial ratio, 0.15 Ϯ 0.26). Similarly, for the inferior vena cava to the aorta, the venous-toarterial ratio averaged 0.24 Ϯ 0.19.
Hepatic Vascular Anatomy
The distribution of hepatic arterial anatomic variants is shown in Table 2 , along with the original observations reported by Michels (15) (Fig 3) . One of the six patients with an accessory left hepatic artery replaced to the left gastric artery (Michels type V) also had a variant of the right hepatic artery-the vessel arose off the proximal portion of the celiac artery. Of the three patients (6%) not classified according to one of the 10 original Michels types, one had a right hepatic artery arising directly from the aorta (Fig 4) ; two had right hepatic arteries arising from the proximal celiac artery and, in addition, in these two, one also had a left gastric artery arising directly from the aorta and the other had a middle hepatic artery arising directly from the aorta.
The right and left main portal veins were identified at volumetric interpolated breath-hold examination in 48 studies (96%). In two patients who had cirrhosis, portal venous occlusion and extensive collateral vessels (cavernous transformation) were observed. In three additional patients, partial thrombosis of the portal vein was depicted at volumetric interpolated breath-hold examination. Variations in intrahepatic portal venous branching were found in eight patients (16%): In five (10%), the portal vein trifurcated into a left main portal branch, right anterior portal branch, and right posterior portal branch (Fig 5) , and in three (6%), the left main portal vein arose from the right anterior portal venous branch.
The anatomy of the right, middle, and left hepatic veins was clearly defined in 43 (86%) of 50 patients. In one patient (2%), the hepatic veins appeared markedly attenuated in the setting of cirrhosis; in four patients (8%), anatomic distortion by tumor limited evaluation of the hepatic veins; and in two patients (4%), inadvertent exclusion of a small portion of the dome from the imaging section precluded depiction of the hepatic venous confluence. The left and middle hepatic veins became confluent just proximal to the hepatocaval junction in 39 (91%) of 43 patients. The two vessels remained distinct to the level of the hepatocaval junction in four patients (9%). Small hepatic veins draining from segment 1 (caudate lobe) directly into the inferior vena cava anteriorly were seen in 39 (78%) of 50 patients. Inferior right hepatic veins draining the right lobe directly into the inferior vena cava were identified in 22 (44%) of 50 patients.
Patients with Cirrhosis versus Patients without Cirrhosis
Volumetric interpolated breath-hold image quality was compared in patients with (n ϭ 17) and those without (n ϭ 34) MR evidence of cirrhosis (Table 3) . Parameters including CNR, relative enhancement ratios, and patient circulation times were all not significantly different for each contrast-enhanced volumetric interpolated breath-hold study. However, portal venous CNR, relative to retroperitoneal fat, was consistently lower in patients with cirrhosis compared with those without cirrhosis, although this difference did not achieve statistical significance (P ϭ a.
b. .06-.25) ( Table 3 ). The venous-to-arterial enhancement ratio of the portal vein to the hepatic artery was significantly lower in patients with cirrhosis, averaging 0.22 Ϯ 0.24 versus 0.47 Ϯ 0.42 for patients without cirrhosis (P ϭ .03).
Reproducibility
Ten patients (20%) subsequently underwent repeat MR imaging of the liver within 6 months (mean, 2 months; range, 5 days to 6 months) of the initial study. Differences in patient circulation times for the two examinations were not significant (mean, 1.4 seconds Ϯ 3.3; maximum, 8 seconds). SI and relative enhancement ratios for the liver and major vessels were not significantly different between repeat and baseline examinations (P Ͼ .1 for all values).
DISCUSSION
The conspicuity of hypervascular masses in the liver at both CT (1-4) and MR (5-8) imaging is greatest during the period when hepatic arterial perfusion dominates, before substantial portal venous enhancement. At least 7% of small hepatomas and other hypervascular lesions can be seen only on arterial phase studies (1-4,8) . Moreover, distinct patterns of enhancement during arterial, portal venous, and equilibrium phase acquisitions can be specific to certain types of hepatic lesions (9, 20) . Hence, for patients suspected of having hepatic lesions, properly timed arterial phase acquisitions can be critical to both depiction and characterization.
Arterial phase CT or MR imaging typically is performed following a fixed imaging delay, usually 15-30 seconds, after the start of intravenous injection of contrast material. However, imaging results vary as a result of differences in circulatory physiology among individuals (21) . Using a test bolus of contrast material to time dynamic 2D gradient-echo MR acquisitions in a study of 28 patients, Earls et al (22) found that the transit time from arm vein to arterial enhancement (patient circulation time) varied between 8 and 32 seconds, whereas peak portal venous enhancement started between 20 and 55 seconds. In the same study, successful arterial phase examinations were achieved in 26 (93%) of 28 patients whose studies were timed to circulation time compared with only 17 (61%) of 28 of those who underwent imaging following a fixed 20-second delay after injection of contrast material.
We implemented a similar test bolus timing examination to obtain arterial phase 3D acquisitions and found the approach efficient and reliable. Overall, 49 (98%) of 50 studies were considered subjectively to have excellent conspicuity of arterial vessels during the arterial phase acquisition. These observations are supported by measurements of a nearly 40-fold increase in hepatic arterial CNR during arterial phase compared with that in nonenhanced images (Table 1) . In a reproducibility study in 10 patients, a volumetric interpolated breath-hold examination in which a timing examination was used resulted in comparable MR imaging results, despite differences in circulation times of up to 8 seconds between studies. These findings highlight the importance of customizing the timing of arterial phase acquisitions for each individual at the time of examination. Overall, the test bolus technique adds less than 4 minutes to table time and has the advantage of being implemented easily with any commercial system without special software or hardware (22, 23) . We emphasize, however, that volumetric interpolated breath-hold examination does not require a timing examination and can also be performed with conventional fixed imaging delays.
One potential limitation to the test bolus approach is the variable effect of breath holding on circulation time, because the test bolus examination is performed during free breathing, whereas volumetric interpolated breath-hold examination is performed during end-expiration breath holding. Krinsky et al (24) found that differences in circulation time with breath holding were as much as 6 seconds when measured at the level of the carotid arteries. One potential solution that remains to be explored is the use of breath holding during the initial portion of the 1-minute test bolus study.
Since periods of hepatic arterial and portal venous enhancement overlap, for acquisition periods that last 20-25 seconds, a mild degree of portal venous enhancement during arterial phase acquisitions is not unexpected. Hepatic parenchymal enhancement during the arterial phase averaged 29% of maximal enhancement, which is comparable to the expected 25%-30% were hepatic arterial supply the only contributor to enhancement (21) . During arterial phase, portal venous enhancement, though not insubstantial, remained less than 40% of arterial enhancement, and similarly, hepatic venous enhancement averaged 15% of arterial enhancement. These results are consistent with our observation that angiographic images, including maximum intensity projection images, can be produced from arterial phase data without substantially overlapping venous contamination (Figs 1, 3, 4) .
Although we did not observe significant differences in enhancement patterns or patient circulation times in patients with cirrhosis compared with those without, we did observe slightly less enhancement of the portal vein on images obtained during both portal venous and equilibrium enhancement phases in patients with cirrhosis, although differences did not achieve statistical significance. Our results do not support the findings of Soyer et al (25) , who observed that patients with cirrhosis have delayed paren- chymal enhancement; however, a limitation of our study was the reliance on MR imaging, which may be less sensitive than histopathologic sampling, for diagnosis of cirrhosis. Better correlation between delayed or impaired portal venous enhancement with severity of portal hypertension may be possible with the advent of fast phase-contrast measurements of portal venous flow patterns (26) . With nearly isotropic 3D imaging, the pitfalls of intersection gaps and partial volume artifacts associated with 2D imaging can be avoided (27, 28) . Other advantages include the opportunity to reformat images in any plane without loss of image resolution. The 3D approach obviates separate repeat 2D acquisitions in additional imaging planes, which are inevitably obtained in the delayed venous phase, that may be required when a 2D strategy is used. We hypothesize that by allowing a 3D assessment of patterns of contrast enhancement and washout, dynamic volumetric interpolated breath-hold examination may improve diagnostic accuracy and confidence in evaluation of parenchymal disease, in particular small hepatic lesions such as hypervascular masses and hemangiomas (Fig 6) .
Using a double dose (0.2 mmol/kg) of gadolinium chelate, Hawighorst et al (9) recently reported application of a 3D MR angiographic sequence for dynamic contrast-enhanced evaluation of hepatic lesions. The imaging technique resulted in anisotropic voxels of 2.5 mm or more and, as an angiographic sequence with asymmetry of data sampling in the read direction and a higher flip angle, was designed to suppress signal from extravascular structures such as hepatic parenchyma. Nevertheless, the authors observed that by using a test bolus of contrast material to determine timing parameters, their dynamic 3D approach allowed analysis of spatial variations of contrast enhancement across time that resulted in accurate characterization of 35 of 35 lesions, including hemangioma, metastasis, hepatocellular carcinoma, and focal nodular hyperplasia.
In addition to lesion depiction and characterization, arterial phase volumetric interpolated breath-hold acquisitions can be used to obtain MR angiograms and venograms without additional imaging time or contrast material (Figs 1, 3-6 ). Accurate knowledge of hepatic arterial anatomy is helpful in several clinical settings, including surgical planning for hepatic transplantation (11) or resection or in planning catheter-related interventional procedures such as chemoembolization. This capability may become even more critical as transplantation with hepatic tissue resected from living related donors becomes more popular (29) . Moreover, the ability to detect both vascular and extravascular disease by using the volumetric interpolated breath-hold approach lends itself to evaluation of cirrhosis or hepatoma and to the postoperative evaluation of hepatic transplants (30) .
One limitation of this study is that conventional angiographic confirmation was not available. However, the distribution of anatomic variants in our study is comparable to that in Michels' original findings (Table 2) . Using a 36-second MR sequence with similar effective pixel size and 0.15 mmol/kg gadopentetate dimeglumine, Kopka et al (31) recently demonstrated agreement between MR angiographic assessment and conventional angiographic assessment of hepatic arterial anatomy in 57 (95%) of 60 patients.
The identification of hepatic portal venous variants can be critical in surgical planning (32) (33) (34) . For example, an accessory inferior hepatic vein can allow preservation of the posteroinferior area of the right lobe despite transection of the right hepatic vein in partial hepatectomy (33) . We identified more inferior hepatic veins (seen in 22 of 50 patients) than previously reported by using CT (18) and ultrasonographic (35) methods, and we attribute the difference to greater spatial resolution and CNR with our technique and to the ability to perform detailed retrospective analysis by using multiplanar reformations. Variations in portal venous anatomy, such as the left portal vein arising from a right portal venous branch, may alter segmental definition and also substantially affect surgical approach (34) . Moreover, multiplanar reformatting of venous phase 3D image sets potentially can improve definition of segmental anatomy (36) and increase the confidence with which hepatic tumors can be localized (37) (38) (39) .
In conclusion, volumetric interpolated breath-hold examination provides high- quality nearly isotropic 3D images for evaluation of hepatic disease and can be performed dynamically with acquisition times of less than 25 seconds. When timed by using a test dose of contrast material, arterial phase 3D volumetric MR images can be obtained reliably and reproducibly for potentially improved depiction and characterization of hepatic lesions, with the added advantage of multiplanar and angiographic reconstruction images that can facilitate surgical or catheter-related interventional planning.
